TRF-1101 Assessment in Sickle Cell Disease

Clinical trial NCT00773890 · TERMINATED

Trial details

NCT number: NCT00773890
Sponsor: TRF Pharma, Inc
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2008-07-01
Primary completion: 2009-05-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.